Baird Medical Investment Holdings Limited (BDMD) concluded trading on Tuesday at a closing price of $7.60, with 89.06 million shares of worth about $676.87 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -30.40% during that period and on December 31, 2024 the price saw a gain of about 623.81%. Currently the company’s common shares owned by public are about 7.29M shares.
Stock saw a price change of 270.73% in past 5 days and over the past one month there was a price change of 210.20%. Year-to-date (YTD), BDMD shares are showing a performance of -29.04% which decreased to -27.06% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.05 but also hit the highest price of $13.52 during that period. The average intraday trading volume for Baird Medical Investment Holdings Limited shares is 61.62K. The stock is currently trading 269.28% above its 20-day simple moving average (SMA20), while that difference is up 208.27% for SMA50 and it goes to -8.66% lower than SMA200.
Baird Medical Investment Holdings Limited (NASDAQ: BDMD) currently have 7.29M outstanding shares and institutions hold larger chunk of about 89.64% of that.
The stock has a current market capitalization of $1.95B and its 3Y-monthly beta is at 0.27. It has posted earnings per share of -$0.55 in the same period. It has Quick Ratio of 0.02 while making debt-to-equity ratio of 0.52. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BDMD, volatility over the week remained 133.21% while standing at 50.01% over the month.
Analysts are in expectations that Baird Medical Investment Holdings Limited (BDMD) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same.
